These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 15835343

  • 1. [Proarrhythmic (torsadogenic) effects of QT-prolonging non-antiarrhythmic drugs].
    Fazekas T, Liszkai G.
    Orv Hetil; 2005 Mar 06; 146(10):451-60. PubMed ID: 15835343
    [Abstract] [Full Text] [Related]

  • 2. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V, Cavero I.
    Minerva Med; 2002 Jun 06; 93(3):181-97. PubMed ID: 12094149
    [Abstract] [Full Text] [Related]

  • 3. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M, Coppa F, Cappucciati C, Brambilla P, d'Allio G, Caverzasi E, Barale F, De Ferrari GM.
    Curr Opin Investig Drugs; 2006 Mar 06; 7(3):256-63. PubMed ID: 16555686
    [Abstract] [Full Text] [Related]

  • 4. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
    Kecskeméti V.
    Neuropsychopharmacol Hung; 2004 Mar 06; 6(1):5-12. PubMed ID: 15125308
    [Abstract] [Full Text] [Related]

  • 5. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S, Marte F, Di Bella G, Currò A, Coglitore S.
    Int J Cardiol; 2008 Nov 12; 130(2):e71-3. PubMed ID: 18255176
    [Abstract] [Full Text] [Related]

  • 6. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K, Dorian P.
    Europace; 2007 Sep 12; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [Abstract] [Full Text] [Related]

  • 7. Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs.
    Hondeghem LM.
    J Cardiovasc Electrophysiol; 2006 Mar 12; 17(3):337-40. PubMed ID: 16643415
    [Abstract] [Full Text] [Related]

  • 8. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia].
    Gury C, Canceil O, Iaria P.
    Encephale; 2000 Mar 12; 26(6):62-72. PubMed ID: 11217540
    [Abstract] [Full Text] [Related]

  • 9. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
    Abi-Gerges N, Philp K, Pollard C, Wakefield I, Hammond TG, Valentin JP.
    Fundam Clin Pharmacol; 2004 Apr 12; 18(2):139-51. PubMed ID: 15066127
    [Abstract] [Full Text] [Related]

  • 10. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
    Lu HR, Vlaminckx E, Van de Water A, Rohrbacher J, Hermans A, Gallacher DJ.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):229-39. PubMed ID: 17054943
    [Abstract] [Full Text] [Related]

  • 11. QT prolongation in guinea pigs for preliminary screening of torsadogenicity of drugs and drug-candidates. II.
    Testai L, Breschi MC, Martinotti E, Calderone V.
    J Appl Toxicol; 2007 Dec 28; 27(3):270-5. PubMed ID: 17265420
    [Abstract] [Full Text] [Related]

  • 12. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
    Steinbeck G.
    Z Kardiol; 1992 Dec 28; 81 Suppl 4():139-43. PubMed ID: 1290290
    [Abstract] [Full Text] [Related]

  • 13. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P, Hreiche R, Turgeon J.
    Can J Cardiol; 2005 Aug 28; 21(10):857-64. PubMed ID: 16107909
    [Abstract] [Full Text] [Related]

  • 14. [Sudden cardiac death and inherited repolarization disorders].
    Gościńska K, Sredniawa B, Pasyk S.
    Przegl Lek; 2002 Aug 28; 59(7):523-6. PubMed ID: 12516242
    [Abstract] [Full Text] [Related]

  • 15. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
    Milberg P, Hilker E, Ramtin S, Cakir Y, Stypmann J, Engelen MA, Mönnig G, Osada N, Breithardt G, Haverkamp W, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun 28; 18(6):647-54. PubMed ID: 17388913
    [Abstract] [Full Text] [Related]

  • 16. Proarrhythmic potential of antimicrobial agents.
    Simkó J, Csilek A, Karászi J, Lorincz I.
    Infection; 2008 Jun 28; 36(3):194-206. PubMed ID: 18454341
    [Abstract] [Full Text] [Related]

  • 17. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
    Milberg P, Pott C, Eckardt L, Breithardt G.
    Dtsch Med Wochenschr; 2008 Dec 28; 133 Suppl 8():S285-9. PubMed ID: 19085808
    [Abstract] [Full Text] [Related]

  • 18. Long QT syndrome caused by noncardiac drugs.
    Viskin S, Justo D, Halkin A, Zeltser D.
    Prog Cardiovasc Dis; 2003 Dec 28; 45(5):415-27. PubMed ID: 12704598
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugs.
    Vieweg WV.
    J Clin Psychiatry; 2002 Dec 28; 63 Suppl 9():18-24. PubMed ID: 12088172
    [Abstract] [Full Text] [Related]

  • 20. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
    Makai A, Rudas L, Liszkai G, Fazekas T.
    Orv Hetil; 2003 Feb 02; 144(5):241-7. PubMed ID: 12647553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.